Rhythm Pharmaceuticals (RYTM) Depreciation & Amortization (CF) (2016 - 2021)
Rhythm Pharmaceuticals (RYTM) posted quarterly Depreciation & Amortization (CF) of $315000.0 for Q3 2021, up 83.14% year-over-year from $172000.0 in Q3 2020, and down 0.63% quarter-over-quarter from $317000.0 in Q2 2021.
Rhythm Pharmaceuticals (RYTM) Depreciation & Amortization (CF) (2016 - 2021) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $315000.0 the latest figure, recorded in Q3 2021.
- In Q3 2021, Depreciation & Amortization (CF) rose 83.14% year-over-year to $315000.0; the TTM figure through Jun 2022 stood at $315000.0 (down 63.71% YoY), while the FY2020 annual figure was $690000.0, down 17.27% from the prior year.
- Depreciation & Amortization (CF) retreated to $315000.0 in Q3 2021 per RYTM's latest filing, from $317000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $317000.0 in Q2 2021 and bottomed at $54000.0 in Q1 2017.
- Historically, Depreciation & Amortization (CF) has averaged $159052.6 across 5 years, with a median of $173000.0 in 2020.
- Annual changes were most pronounced in 2019 — Depreciation & Amortization (CF) soared 301.64% — and 2020, when it plunged 31.84%.
- Rhythm Pharmaceuticals' Depreciation & Amortization (CF) stood at $60000.0 in 2017, then soared by 256.67% to $214000.0 in 2018, then dropped by 10.75% to $191000.0 in 2019, then retreated by 6.81% to $178000.0 in 2020, then soared by 76.97% to $315000.0 in 2021.
- Business Quant data shows RYTM's Depreciation & Amortization (CF) at $315000.0 in Q3 2021, $317000.0 in Q2 2021, and $201000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 40.52 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 315,000.00 |
| Sep 30, 2021 | 315,000.00 |
| Jun 30, 2021 | 317,000.00 |
| Jun 30, 2021 | 317,000.00 |
| Mar 31, 2021 | 201,000.00 |
| Mar 31, 2021 | 201,000.00 |
| Dec 31, 2020 | 178,000.00 |
| Dec 31, 2020 | 178,000.00 |
| Sep 30, 2020 | 172,000.00 |
| Sep 30, 2020 | 172,000.00 |
| Jun 30, 2020 | 173,000.00 |
| Jun 30, 2020 | 173,000.00 |
| Mar 31, 2020 | 167,000.00 |
| Mar 31, 2020 | 167,000.00 |
| Dec 31, 2019 | 191,000.00 |
| Dec 31, 2019 | 191,000.00 |
| Sep 30, 2019 | 191,000.00 |
| Sep 30, 2019 | 191,000.00 |
| Jun 30, 2019 | 207,000.00 |
| Jun 30, 2019 | 207,000.00 |